The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Biomrieux competitive analysis

Loading summary...

Latest patents of Biomrieux opposed by its competitors

Explore Biomrieux's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP4133277
Aug 14, 2024Method For Determining The Risk Of Incidence Of A Care-Associated Infection In A Patient1
EP3174994
Dec 7, 2022Characterization Of Microorganisms Via Maldi-Tof1
EP2948548
Nov 23, 2022Method For The Specific Isolation Of Nucleic Acids Of Interest1
EP3619533
Sep 28, 2022Method For Detecting An Immune Cellular Response2
EP2955518
Jan 26, 2022Unmasking Endotoxins In Solution1
EP3155422
Jan 26, 2022Unmasking Endotoxins In Solution1
EP3332028
Jan 6, 2021Genetic Resistance Prediction Against Antimicrobial Drugs In Microorganism Using Structural Changes In The Genome1
EP2449130
Nov 4, 2020Method For Neutralization Of Antibiotics In A Culture Medium1
EP2465940
Jan 10, 2018Medium For The Specific Detection Of Resistant Organisms1

Latest PTAB cases involving Biomrieux

Discover the latest PTAB cases involving Biomrieux, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Biomrieux with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BIOMRIEUX - 8 - -
AQUINOV1 - - -
BRUKER DALTONICS24 - -
SIMMONS & SIMMONS7 - - -